台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    91.8
  • 漲跌
    ▲0.9
  • 漲幅
    +0.99%
  • 成交量
    337
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-永豐金-南投 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-南投 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/3000.00191.5090.90-1320-0.31%
2024/05/2400.001100.00105.00-1298-0.33%
2024/05/23192.30597.34100.50-4286-1.40%
2024/05/2100.00688.3793.00-6250-2.39%
2024/05/20182.501086.3086.30-9238-3.77%
2024/05/13974.3300.0074.0092583.48%
2024/03/13458.3800.0057.4042261.77%
2024/03/08861.9500.0061.0082143.73%
2024/03/07362.8000.0064.5032091.43%
2024/02/26451.7500.0052.1041812.21%
2024/02/22148.0000.0051.1011820.55%
2024/02/21746.9400.0047.0071823.83%
2024/02/201750.7600.0048.30171809.40%
2024/02/19852.4400.0052.5081844.34%
2024/01/1200.00739.8540.55-7193-3.63%
2023/10/1800.00228.0528.05-271-2.81%
2022/08/0400.00112.4012.40-1109-0.92%
2022/08/01212.9500.0013.0021111.80%
2022/07/27113.8500.0014.1511090.92%
2022/07/25113.7500.0013.751831.19%
2022/05/0900.00315.0014.45-3143-2.09%
2022/05/06315.2000.0015.1531412.12%
2022/04/1900.001015.4715.35-10105-9.45%
2022/04/181016.8500.0016.95109210.85%
2021/05/1900.00117.1016.95-1547-0.18%
2021/05/18118.9500.0017.9015350.19%
2021/02/2400.001016.7516.85-10197-5.07%
2021/02/231018.0000.0017.45101935.18%
2020/10/2300.00219.7519.70-2548-0.36%
2020/10/22222.0000.0021.2025610.36%
2020/10/0600.00117.3517.10-11,075-0.09%
2020/09/08119.8500.0019.9511,6490.06%
2020/08/0700.000.324.1024.20-0.32,307-0.01%
2020/07/2900.00124.8025.55-12,273-0.04%
2020/07/240.127.0000.0027.000.12,2360.00%
2020/07/230.129.0500.0028.800.12,2330.00%
2020/07/220.129.9500.0030.000.12,2040.00%
2020/07/1700.00127.7026.15-12,068-0.05%
2020/07/151031.5400.0030.80101,9830.50%
2020/07/10127.1000.0028.7011,6660.06%
2020/07/0900.00126.1026.10-11,530-0.07%
2020/06/2400.001022.3021.30-101,402-0.71%
2020/06/2200.00522.5022.70-51,400-0.36%
2020/06/17124.4500.0025.3511,3500.07%
2020/06/161026.52125.1025.9091,2940.70%
2020/06/15124.1000.0024.2011,2070.08%
2020/06/1200.002121.4422.00-211,124-1.87%
2020/06/11121.00120.4021.0001,0770.00%
2020/06/10118.2000.0019.1019850.10%
2020/06/0300.00517.5017.60-5963-0.52%
2020/06/02416.75316.8016.6019660.10%
2020/06/01117.7000.0017.7019680.10%
2020/05/28520.14617.5918.50-1978-0.10%
2020/05/27623.752019.4519.45-14947-1.48%
2020/05/222017.3000.0017.90209302.15%
2020/05/062013.4900.0012.65207612.63%
2020/04/2200.0019.309.30-1694-0.14%
2020/04/2000.0049.769.74-4692-0.58%
2020/04/1700.0049.779.73-4691-0.58%
2020/04/1649.7100.009.7146880.58%
2020/04/0900.0019.289.90-1692-0.14%
2020/04/0819.1919.259.2406950.00%
2020/04/0618.9300.008.8716860.15%
2020/03/2700.0018.798.80-1675-0.15%
2020/03/2347.7000.007.8046570.61%
2020/03/12110.4500.0010.3515840.17%
2020/03/11111.8500.0011.5015630.18%
2020/03/0900.00114.7514.15-1523-0.19%
2020/03/06114.0000.0014.7515020.20%
2020/03/0400.00215.1014.95-2459-0.44%
2020/03/03213.9000.0015.4524340.46%
2020/03/0200.00314.0714.60-3397-0.75%
2020/02/27213.3500.0013.3023590.56%
2020/02/26113.85813.5014.05-7321-2.17%
2020/02/25812.021412.2512.80-6264-2.27%
2020/02/241011.53211.5011.6582183.65%
2020/02/20210.0500.0010.0021741.15%
2020/01/0700.001010.4010.45-10101-9.83%
2020/01/03510.9800.0010.905955.25%
2020/01/02510.85310.8510.852792.52%
2019/12/1700.00510.0510.05-565-7.67%
2019/12/1300.0059.609.65-562-7.98%
2019/12/1159.7300.009.775647.79%
2019/09/1200.00111.4011.25-1177-0.56%
2019/09/11111.3000.0011.8011700.59%
2019/08/2600.0039.779.94-3148-2.02%
2019/07/04311.3000.0011.453943.18%
2019/02/26311.9500.0012.0531252.39%
2019/02/2200.00112.2512.20-1123-0.81%
2019/02/21112.4500.0012.3511220.81%
2019/01/1400.00314.1014.00-394-3.19%
2018/11/29312.3500.0012.303853.51%
2018/09/12217.1000.0016.8521211.65%
2018/09/07216.8000.0016.802982.02%
2018/08/13218.3500.0018.0021191.67%
2018/08/02318.0000.0017.8531232.42%
2018/08/01318.2000.0018.2031262.37%
2018/04/2700.00319.6019.60-3377-0.79%
2018/04/10322.8500.0022.8531891.58%
2018/02/2700.00118.9018.90-1208-0.48%
2018/01/0200.00220.2319.75-2174-1.15%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音